Scleroderma, Systemic: all 695 studies
Page 6 of 7. Open to participants first (224), then studies with results posted, then the rest; newest registration first within each.
- Neutrophil Extracellular Traps in Systemic SclerosisCompletedNCT03374618Not applicable
- A Pilot-Study of Sirolimus for the Treatment of Systemic SclerosisStatus unknownNCT03365869Phase 2
- Evaluation of Calcinosis in Systemic SclerosisCompletedNCT03340194
- Itch and Clinacal Caracteristics in Systemic SclerosisCompletedNCT03297580
- Transcutaneous Electroacupuncture for Gastric Complications of SclerodermaCompletedNCT03294616Not applicable
- Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.CompletedNCT03271333
- Evaluation of Aesthetic Impact in Patients With Systemic SclerosisCompletedNCT03271320
- Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble SwallowingWithdrawnNCT03270722Not applicable
- Role of Macrophage Migratory Inhibitory Factor in Systemic SclerosisStatus unknownNCT03268330
- Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural EnvironmentCompletedNCT03262922
- Health-related Quality of Life in Korean Patients With Rheumatic DiseasesStatus unknownNCT03257878
- Impact of Education and Training of Modified Rodnan Skin Scoring on the Reliability of TestStatus unknownNCT03219606Not applicable
- Brentuximab Vedotin in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT03198689Phase 2
- Intraoperative ICG for Systemic SclerosisWithdrawnNCT03155464Phase 4
- Echo Systemic SclerosisStatus unknownNCT03143413
- The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard TherapyCompletedNCT03141125Not applicable
- Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept StudyCompletedNCT03120533Phase 1/2
- Pirfenidone as Treatment of Skin Fibrosis in Systemic SclerosisStatus unknownNCT03068234Phase 2/3
- The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )Status unknownNCT03059979Early Phase 1
- The Effects of Exercise in Patients With Systemic SclerosisCompletedNCT03058887Not applicable
- To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT03053739Phase 4
- Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudCompletedNCT03027674Early Phase 1
- Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic SclerosisCompletedNCT03007004Phase 2
- ADMSCs for the Treatment of Systemic SclerosisCompletedNCT02975960Not applicable
- Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung DiseaseCompletedNCT02896205Phase 3
- The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)CompletedNCT02887495
- SCLERoderma et Adipose-DErived Stroma CellsStatus unknownNCT02866552Phase 2
- Duke Scleroderma Clinic Patient RegistryTerminatedNCT02851875
- Novel Rehabilitation Strategies to Improve Arm Function in Patients With SclerodermaCompletedNCT02837549Not applicable
- Optical Elastography of Systemic Sclerosis SkinCompletedNCT02835196
- Vocal Intervention in Systemic SclerosisStatus unknownNCT02821663Not applicable
- Seoul National University Hospital Systemic Sclerosis CohortStatus unknownNCT02819947
- FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMICStatus unknownNCT02808481
- Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital UlcersCompletedNCT02801305Phase 2
- Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis PatientsCompletedNCT02789670
- Obstructive Sleep Apnea in Scleroderma and Pulmonary InvolvementCompletedNCT02740569
- Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic SclerosisCompletedNCT02733978Not applicable
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingNCT02682511Phase 2
- The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic SclerosisCompletedNCT02655640
- Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort StudyTerminatedNCT02642146
- Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic SclerosisCompletedNCT02636127Not applicable
- A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)WithdrawnNCT02588625Phase 2
- Vasculopathy, Inflammation and Systemic SclerosisCompletedNCT02562079Not applicable
- Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic SclerosisTerminatedNCT02558543Phase 2
- CSL Behring Sclero XIIIStatus unknownNCT02551042Phase 2
- Systemic Sclerosis Clinical and Biomarker StudyWithdrawnNCT02531009
- Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic SclerosisCompletedNCT02503644Phase 2
- The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic SclerosisCompletedNCT02480335Phase 4
- Light Treatment for Scleroderma Finger UlcersCompletedNCT02472743Not applicable
- Safety & Suitability of Dabigatran to Inhibit Thrombin in SclerodermaCompletedNCT02426229Phase 1
- Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)CompletedNCT02396238Not applicable
- A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy SubjectsCompletedNCT02386436Phase 1
- Oral Manifestations of Systemic SclerosisTerminatedNCT02371005Not applicable
- Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety TrialCompletedNCT02349009Phase 1/2
- Evaluating Pulmonary Arterial Hypertension in Patients With Systemic SclerosisWithdrawnNCT02339961Not applicable
- Treatment Outcome in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT02339441
- Endothelial Microparticles in Systemic Sclerosis Pulmonary HypertensionCompletedNCT02331225
- Scleroderma Treatment With Celution Processed ADRCs RegistryWithdrawnNCT02328625
- Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic SclerosisStatus unknownNCT02302352Phase 3
- Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)WithdrawnNCT02278445Not applicable
- Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT02260557Phase 2
- Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)TerminatedNCT02246348Not applicable
- Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by UltrasoundTerminatedNCT02243111Not applicable
- Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT02228850Phase 2
- Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem CellsCompletedNCT02213705Phase 1/2
- Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic SclerosisCompletedNCT02212249Not applicable
- EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSISStatus unknownNCT02206672Not applicable
- Divalproex Sodium in the Treatment of the Cutaneous Manifestations of SclerodermaWithdrawnNCT02166229Phase 1/2
- The Role of Gastroesophageal Reflux in Scleroderma Pulmonary FibrosisStatus unknownNCT02136394
- Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic SclerosisCompletedNCT02105818
- Calcinosis in a Single-Center Scleroderma PopulationCompletedNCT02062125
- Zibotentan Better Renal Scleroderma Outcome StudyCompletedNCT02047708Phase 2
- Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized SclerodermaStatus unknownNCT02002897Not applicable
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
- Lower Urinary Tract Symptoms in Systemic SclerosisCompletedNCT01971294
- Novel Screening Strategies for Scleroderma PAHCompletedNCT01959815
- Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic SclerosisStatus unknownNCT01943968Not applicable
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Autologous Stem Cell Transplantation for Progressive Systemic SclerosisCompletedNCT01895244Phase 2
- A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With SclerodermaCompletedNCT01881529
- Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
- Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic SclerosisStatus unknownNCT01858259
- Conception of an ICF Core Set for Systemic SclerosisCompletedNCT01848418
- Development and Prevention of Pulmonary Hypertension in Systemic SclerosisStatus unknownNCT01840748
- Prevention and Treatment of Digital Ulcers in Systemic SclerosisStatus unknownNCT01836263
- Improvement of Hand Dysfunction by Arthritis in Systemic SclerosisStatus unknownNCT01834157
- Development and Prevention of Severe Heart Disease in Systemic SclerosisStatus unknownNCT01829126
- Oral Health and People With Systemic SclerosisCompletedNCT01817361
- Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot StudyCompletedNCT01813578Not applicable
- Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic SclerosisCompletedNCT01813279Not applicable
- Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal DiseaseStatus unknownNCT01804959Phase 2
- Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for MorpheaCompletedNCT01799174Not applicable
- IVIG Treatment in Systemic SclerosisStatus unknownNCT01785056Not applicable
- Morbidity and Mortality Follow Up for the Scleroderma Lung StudyCompletedNCT01762449
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.CompletedNCT01743612Not applicable
- Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary HypertensionCompletedNCT01729611
- The CARRA RegistryCompletedNCT01697254
- Sacroiliitis in Systemic SclerosisCompletedNCT01673633
- Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and CoughCompletedNCT01667042